Skip to Content

Alexandria Pharmaceutical & Chemical Industries SA AXPH

Morningstar Rating
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

AXPH is trading at a 19% discount.
Price
EGP 225.72
Fair Value
EGP 231.75
Uncertainty
Extreme
1-Star Price
EGP 5,726.55
5-Star Price
EGP 11.35
Economic Moat
Kxdvx
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if AXPH is a good fit for your portfolio.

Trading Information

Previous Close Price
Day Range
52-Week Range
Bid/Ask
/
Market Cap
Volume/Avg
/

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
5.75%
Dividend Yield (Forward)
5.75%
Total Yield
5.75%

Company Profile

Alexandria Pharmaceutical & Chemical Industries SA is an Egypt based manufacturer of pharmaceutical and medical application products. It offers syrups and suspensions, ampoules, tablets, capsules, adhesive plasters, dental cartridges, medicated adhesive and gels, among others. The organization offers medical products for humans, veterinary products and medical appliances.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Small Growth
Total Number of Employees

Valuation

Metric
AXPH
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
AXPH
Quick Ratio
Current Ratio
Interest Coverage
Quick Ratio
No chart available

Profitability

Metric
AXPH
Return on Assets (Normalized)
Return on Equity (Normalized)
Return on Invested Capital (Normalized)
Return on Assets
No chart available
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
ZTS
Zoetis Inc Class ADnjqhhkcGkdj$70.0 Bil
MKKGY
Merck KGaA ADRBynwkzhcLmhjbhz$68.1 Bil
HLN
Haleon PLC ADRXfrywrzLlstc$36.5 Bil
TEVA
Teva Pharmaceutical Industries Ltd ADRHdkxfdvtBkkb$14.3 Bil
VTRS
Viatris IncWbldlljpPrtq$13.2 Bil
RDY
Dr Reddy's Laboratories Ltd ADRDzhvsscdHgy$12.0 Bil
CTLT
Catalent IncSrrthdnmCylgch$10.1 Bil
PRGO
Perrigo Co PLCTlnkbcgYgdq$4.1 Bil
CURLF
Curaleaf Holdings IncZbmdjpckWrxw$3.7 Bil
PBH
Prestige Consumer Healthcare IncCtmrpmljJgwsngf$3.4 Bil

Sponsor Center